Ads
related to: eli lilly- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Press Releases
Search results
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
Motley Fool via Yahoo Finance· 1 day agoEli Lilly (NYSE: LLY) can't stop grabbing headlines. The pharmaceutical company has made quite a bit...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 2 days agoShares of Eli Lilly LLY rose nearly 3% on Tuesday after it reported detailed one-year results from...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
NBC Washington· 3 days agoThe rivalry between Eli Lilly and Novo Nordisk extends beyond a buzzy class of weight loss and...
IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
Investor's Business Daily· 3 days agoEli Lilly is Tuesday's IBD Stock Of The Day after shares surged into a buy zone, again, on promising...
'Ozempic breasts' to 'Ozempic face': What you need to know about weight loss drug side effects
Euronews via Yahoo News· 5 days agoFor instance, in 2023, American Jaclyn Bjorklund launched legal proceedings against Novo Nordisk and...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 23 hours agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual...
Clearfield Progress· 14 hours agoEli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), Retevmo® (selpercatinib; a rearranged ...
Eli Lilly stock maintains price target with Jefferies' buy rating By Investing.com
Investing.com· 4 days agoOn Monday, Jefferies maintained a confident stance on Eli Lilly (NYSE:LLY) shares, reiterating a Buy rating and a price target of $915.00. The affirmation ...
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market? | The Motley Fool
The Motley Fool· 5 days agoEli Lilly (LLY -0.03%) sells a broad portfolio of products, but two in particular have helped...
2 Stocks That Could 10x by 2035
Motley Fool via Yahoo Finance· 15 minutes agoIt is developing an anti-obesity medicine, an area dominated by two of the largest pharmaceutical companies in the world, Novo Nordisk and Eli Lilly....
Ad
related to: eli lilly
